Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) Return on Capital Employed (2016 - 2025)

Traws Pharma (TRAW) has disclosed Return on Capital Employed for 13 consecutive years, with 46.55% as the latest value for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 2026.0% year-over-year to 46.55%; the TTM value through Dec 2025 reached 46.55%, down 2026.0%, while the annual FY2025 figure was 2.69%, 889.0% up from the prior year.
  • Return on Capital Employed hit 46.55% in Q4 2025 for Traws Pharma, down from 2.57% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.32% in Q4 2021 and bottomed at 46.55% in Q4 2025.
  • Average Return on Capital Employed over 5 years is 7.08%, with a median of 1.02% recorded in 2023.
  • Year-over-year, Return on Capital Employed plummeted -2499bps in 2024 and then surged 2334bps in 2025.
  • Traws Pharma's Return on Capital Employed stood at 0.32% in 2021, then plummeted by -83bps to 0.59% in 2022, then plummeted by -122bps to 1.3% in 2023, then crashed by -1926bps to 26.29% in 2024, then crashed by -77bps to 46.55% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 46.55%, 2.57%, and 2.03% for Q4 2025, Q3 2025, and Q2 2025 respectively.